Goldman Sachs Group Inc Biogen Inc. Put Options Transaction History

Goldman Sachs Group Inc

12 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2023 May 14, 2024	BUY	$275.25 - $318.06 $798,225 - $922,374	2,900 Added 31.87%	12,000 $3.42 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $798,225 - $922,374	2,900 Added 31.87%	12,000 $3.42 Million
Q1 2023 May 14, 2024	SELL	$256.56 - $292.34 $14.5 Million - $16.5 Million	-56,500 Reduced 86.13%	9,100 $2.53 Million
Q1 2023 May 11, 2023	SELL	$256.56 - $292.34 $14.5 Million - $16.5 Million	-56,500 Reduced 86.13%	9,100 $2.53 Million
Q4 2022 May 14, 2024	BUY	$252.44 - $306.72 $6.94 Million - $8.43 Million	27,500 Added 72.18%	65,600 $18.2 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $6.94 Million - $8.43 Million	27,500 Added 72.18%	65,600 $18.2 Million
Q3 2022 May 14, 2024	BUY	$194.69 - $268.46 $1.95 Million - $2.68 Million	10,000 Added 35.59%	38,100 $10.2 Million
Q3 2022 Nov 10, 2022	BUY	$194.69 - $268.46 $1.95 Million - $2.68 Million	10,000 Added 35.59%	38,100 $10.2 Million
Q2 2022 May 14, 2024	BUY	$187.54 - $223.02 $5.27 Million - $6.27 Million	28,100 New	28,100 $5.73 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $1.57 Million - $1.98 Million	8,100 Added 40.5%	28,100 $5.92 Million
Q4 2021 Feb 14, 2022	SELL	$223.92 - $287.77 $3.36 Million - $4.32 Million	-15,000 Reduced 42.86%	20,000 $4.8 Million
Q3 2021 Nov 10, 2021	BUY	$282.99 - $369.05 $9.9 Million - $12.9 Million	35,000 New	35,000 $9.91 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.